Celularity Inc. Retained Earnings
Celularity Inc. (CELU) had Retained Earnings of -$991.48 million as of 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-04-30
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$991.48M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$967.10M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$944.02M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$919.50M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2025-12-31 | -$991.48M 10-K · filed 2026-04-30 | |
| 2025-09-30 | -$967.10M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$944.02M 10-Q · filed 2025-08-29 | |
| 2025-03-31 | -$919.50M 10-Q · filed 2025-08-29 | |
| 2024-12-31 | -$899.68M 10-K · filed 2026-04-30 | |
| 2024-09-30 | -$886.39M 10-Q · filed 2024-12-06 | |
| 2024-06-30 | -$870.29M 10-Q · filed 2024-11-07 | |
| 2024-03-31 | -$863.80M 10-Q · filed 2024-10-16 | |
| 2023-12-31 | -$841.79M 10-K · filed 2025-05-08 | |
| 2023-09-30 | -$851.34M 10-Q · filed 2024-01-03 | |
| 2023-06-30 | -$757.46M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$709.51M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | -$645.50M 10-K · filed 2024-07-30 | |
| 2022-09-30 | -$669.93M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$674.73M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$722.55M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$663.68M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$659.64M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$47.41M 10-Q · filed 2021-08-19 | |
| 2021-03-31 | -$39.58M 10-Q · filed 2021-05-24 | |
| 2020-12-31 | -$563.56M 10-K · filed 2022-03-31 | -$118.42K 10-K · filed 2021-03-04 |
| 2020-09-30 | $3.36M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $3.39M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $3.54M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $3.88M 10-K/A · filed 2021-05-24 | $2.51M 10-K · filed 2020-03-24 |
| 2019-09-30 | $1.75M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $633.44K 10-Q · filed 2019-08-07 | |
| 2018-12-31 | -$1.10K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |